It's How Medicine Should Be®

Translate

French German Italian Portuguese Russian

Colonoscopy Research Study

Clinical Trial Title: 
R01 colonoscopy research study.
Clinical Trial Protocol ID: 
13102201
Clinical Trial Investigator Name: 
Ece Mutlu, MD
Clinical Trial Protocol Description: 

The purpose of this study is to compare the gut microbiome and body composition in patients of different racial/ethnic backgrounds in an effort to learn more about the causes of colon cancer and the reason for differing rates of colon cancer among different racial and ethnic groups.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Are scheduled for a colonoscopy at Rush University Medical Center for screening or surveillance purposes.
  • Are nbetween the ages of 45 and 75.
  • Are relatively healthy: Have no chronic kidney, heart, or liver disease.

You will be excluded from the study if any of the following criteria apply to you:

  • Are currently taking prebiotics, probiotics, or fiber supplements; or antibiotics within the last 2 months.
  • Are currently on an anticoagulant/blood thinner.
  • Have had a menstrual period within the last 6 months.

This is a partial list of inclusion and exclusion criteria.

Clinical Trial Area: 
Digestive Disorders
Gastrointestinal Cancers
Contact Phone: 
(312) 942-3466
Contact Name: 
GI Research